General Thoracic

Multimodal Treatment of Pleural Mesothelioma after the MARS-2 trial: Will We Change Our Ways?

Saturday, January 25, 2025

10:15am – 11:45am PT

Location: 408A

Moderator(s)

Boris Sepesi, MD

Director of Thoracic Surgery and Thoracic Surgical Oncology
Sarah Cannon Cancer Network at Swedish Medical Center, Englewood, Colorado
Englewood, Colorado, United States
Ian Bostock, MD MS

Associate Professor
Miami Cancer Institute
Miami, Florida, United States

Presentations:

10:15am – 10:23am PT

The New IASLC TNM Pleural Mesothelioma Staging and Its Effect on Treatment Options
Invited Speaker: Valerie Rusch, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
10:23am – 10:31am PT

The Role of Pleurectomy and Decortication in Pleural Mesothelioma: How I Do It
Invited Speaker: Andrea Wolf, MD, MPH (she/her/hers) – The Icahn School of Medicine at Mount Sinai
10:31am – 10:39am PT

Novel Perioperative Analgesia Modalities During Pleurectomy and Decortication for Pleural Mesothelioma
Invited Speaker: Jeffrey B. Velotta, MD, FACS – Kaiser Permanente Oakland Medical Center, UCSF Department of Surgery, Kaiser Permanente Bernard J. Tyson School of Medicine
10:39am – 10:50am PT

Panel Discussion
10:50am – 11:00am PT

Updated Post-Recurrence Survival Outcomes in Patients Undergoing Pleurectomy/Decortication for Pleural Mesothelioma
Presenting Author: Akifumi Nakamura, PhD MD (he/him/his) – Hyogo Medical University
11:00am – 11:10am PT

Prolonged Survival is Possible in Mesothelioma Patients Managed Non-Operatively: A National Cancer Database Analysis
Presenting Author: Peter L. Zhan, MD – Yale University
11:10am – 11:18am PT

Neoadjuvant Immunotherapy in the Treatment of Pleural Mesothelioma
Invited Speaker: Bryan M. Burt, MD – University of California, Los Angeles
11:18am – 11:26am PT

Adjuvant Systemic and Immunotherapy Options in the Treatment of Pleural Mesothelioma
Invited Speaker: Jennifer Marie Suga, MD MPH (she/her/hers) – The Permanente Medical Group
11:26am – 11:45am PT

Panel Discussion